Lucid Diagnostics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LUCD research report →
About the company
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma.
- CEO
- Lishan Aklog
- IPO
- 2021
- Employees
- 72
- HQ
- New York City, NY, US
Price Chart
- Market Cap
- $109.47M
- P/E
- -2.30
- P/S
- 21.32
- P/B
- 27.27
- EV/EBITDA
- -2.46
- Div Yield
- 0.00%
- Gross Margin
- -40.03%
- Op Margin
- -959.64%
- Net Margin
- -876.72%
- ROE
- -370.21%
- ROIC
- -159.95%
- Revenue
- $4.71M · 8.28%
- Net Income
- $-58,010,000 · -27.41%
- EPS
- $-0.69 · 34.29%
- Op Income
- $-49,640,000
- FCF YoY
- -3.79%
- 52W High
- $1.63
- 52W Low
- $0.90
- 50D MA
- $1.04
- 200D MA
- $1.15
- Beta
- 1.07
- Avg Volume
- 1.18M
Get TickerSpark's AI analysis on LUCD
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 20, 26 | Matheis Dennis | buy | 245,000 |
| Mar 23, 26 | Lee Victoria Tou-ho | other | 100,000 |
| Mar 23, 26 | Lee Victoria Tou-ho | other | 0 |
| Feb 20, 26 | Aklog Lishan | other | 2,170,000 |
| Feb 20, 26 | Matheis Dennis | other | 123,000 |
| Feb 20, 26 | White Debra | other | 123,000 |
| Feb 20, 26 | Sparks Ronald M | other | 123,000 |
| Feb 20, 26 | SOKOLOV JACQUE J | other | 123,000 |
| Feb 20, 26 | PALUMBO JOHN R | other | 123,000 |
| Feb 20, 26 | Lapidus Stanley | other | 123,000 |
Our LUCD coverage
Recent articles, reports, and earnings notes.
No research on LUCD yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LUCD report →Similar companies
Peers in the same neighborhood.